The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of sustained MRD negativity for up to 5 years on long-term outcome of transplant-eligible newly diagnosed multiple myeloma patients enrolled in the randomized phase 2 FORTE trial.
 
Mattia D'Agostino
Honoraria - GlaxoSmithKline; Janssen; Sanofi
Consulting or Advisory Role - Adaptive Biotechnologies; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Sanofi
Research Funding - Janssen (Inst)
 
Giuseppe Bertuglia
No Relationships to Disclose
 
Delia Rota-Scalabrini
No Relationships to Disclose
 
Angelo Belotti
Consulting or Advisory Role - Amgen; Celgene; GlaxoSmithKline; Janssen Oncology; Takeda
 
Laura Paris
Honoraria - Amgen; Bristol-Myers Squibb; Johnson & Johnson; Menarini; Sanofi
Consulting or Advisory Role - Johnson & Johnson
 
Paolo Corradini
Honoraria - Janssen; Kite, a Gilead company; Novartis; Roche; Takeda
Consulting or Advisory Role - Gilead Sciences; Incyte; Janssen; Kite/Gilead; Novartis; Roche; Sanofi; Takeda
Speakers' Bureau - BMSi
Travel, Accommodations, Expenses - BeiGene; Gilead Sciences; Janssen; Kite, a Gilead company; Novartis; Takeda
 
Micol Quaresima
Consulting or Advisory Role - Novartis
 
Antonio Spadano
Travel, Accommodations, Expenses - Amgen; Celgene; Janssen
 
Giovanni De Sabbata
No Relationships to Disclose
 
Elona Saraci
Honoraria - Becton Dickinson
 
Paolo De Fabritiis
No Relationships to Disclose
 
Angelo Palmas
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Janssen
 
Renato Zambello
Consulting or Advisory Role - Amgen; Celgene; GlaxoSmithKline; Janssen; Takeda
 
Maria Teresa Petrucci
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Johnson & Johnson; Menarini; Oncopeptides; Pfizer; Sanofi; Takeda
 
Massimo Offidani
Honoraria - Bristol-Myers Squibb; Celgene; Janssen
Consulting or Advisory Role - Janssen
 
Elena Zamagni
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen-Cilag; Oncopeptides; Pfizer; Roche; Sanofi; Takeda
Consulting or Advisory Role - Amgen; BMS GmbH & Co. KG; Celgene; Janssen-Cilag; Pfizer; Sanofi
Travel, Accommodations, Expenses - Amgen; Celgene; Janssen
 
Benedetto Bruno
Honoraria - Novartis
 
Mario Boccadoro
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis; Sanofi
Consulting or Advisory Role - GlaxoSmithKline; Janssen
Research Funding - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Mundipharma; Novartis; Sanofi
 
Pellegrino Musto
Honoraria - Amgen; Celgene/Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Sanofi; Takeda
 
Francesca Gay
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen; Kite, a Gilead Company; Oncopeptides; Pfizer; Roche; Sanofi; Takeda